Cargando...
Gene therapy in an era of emerging treatment options for hemophilia B
Factor IX deficiency (hemophilia B) is less common than factor VIII deficiency (hemophilia A) and innovations in therapy for hemophilia B have generally lagged behind those for hemophilia A. Recently the first sustained correction of the hemophilia bleeding phenotype by clotting factor gene therapy...
Gardado en:
| Publicado en: | J Thromb Haemost |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4712690/ https://ncbi.nlm.nih.gov/pubmed/26149016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.12957 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|